Speakers

Dario Neri

Co-CEO and CSO, Professor

Philogen & ETH Zürich

Khursheed Anwer

Chief Scientific Officer & Executive Vice President

Celsion

Christian Klein

Head Oncology Programs, Department Head Cancer Immunotherapy Discovery 3

Roche

Giovanni Abbadessa

Global Head of Oncology Early Development

Sanofi

Irena Adkins

Science Pharmacology Lead

SOTIO Biotech

Katherine Harris

Vice President – Discovery

Amgen

Hariz Hassan

Director - Clinical Development

BioNTech

Cinthia Pastuskovas

Principal Scientist

Merck & Co

Ekta Patel

Director – Translational

Xilio Therapeutics

Michael Schmidt

Chief Scientific Officer

Ankyra Therapeutics

Jamie Spangler

Assistant Professor - Biomedical, Chemical & Biomolecular Engineering

Johns Hopkins

Michael Atkins

Deputy Director

Center & William M Scholl Professor and ViceChair Department of Oncology and Professor of Medicine, Georgetown University Medical Center

Jonathan Davis

Head of Innovation

Invenra

Patrizia Murer

Head of Protein Engineering

Anaevon

Valerie Pivorunas

Associate Scientific Director, Precision Medicine Immunology

AbbVie

Roberto De Luca

Head of Therapeutic Antibodies

Philogen

Ignacio Moraga

Principal Investigator

University of Dundee

Cynthia Seidel-Dugan

Chief Scientific Officer

Werewolf Therapeutics

Bridget O’Keeffe

Vice President, Clinical Development

OncoSec Medical

Mathias Vormehr

Director - Cancer Vaccines

BioNTech

Bradford McRae

Senior Director - Immunology Discovery

AbbVie

Carl Walkey

Senior Vice President - Corporate Development

Neoleukin Therapeutics

Reshma Singh

Associate Director, Cell Therapies Translational Medicine

Takeda

Glareh Azadi

Associate Principal Scientist

Merck & Co

Willem Overwijk

Vice President - Oncology Research

Nektar Therapeutics

Volker Schellenberger

President & Chief Executive Officer

Amunix Pharmaceuticals

Jon Wigginton

Chairman, Scientific Advisory Board & Senior Advisor

Cullinan Oncology

Nicki Panoskaltsis

Associate Professor, Department of Hematology & Medical Oncology

Winship Cancer Institute, Emory University School of Medicine

Pushpa Jayaraman

Associate Director

Novartis

Paula Fraenkel

Executive Director Global Project Lead

AstraZeneca

Nicolas Poirier

Chief Scientific Officer

OSE Immunotherapeutics

Nadia Luheshi

Global Product Leader

AstraZeneca

Jeff Nelson

Product Manager - Biologics

Promega

WORKSHOPS
FULL EVENT GUIDE